The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

Mar. 29, 2021
Applicants:

Agv Discovery, Montpellier, FR;

Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;

Centre National DE LA Recherche Scientifique (Cnrs), Aris, FR;

Universite DE Montpellier, Montpellier, FR;

Inventors:

Jean-François Guichou, Uchaud, FR;

Cédric Bories, Jacou, FR;

Clément Geoffroy, Vergeze, FR;

Charline Duquenne, Saint Bres, FR;

Muriel Gelin, Clapiers, FR;

Gilles Labesse, Montpellier, FR;

Yannick Bessin, Montpellier, FR;

Loic Mathieu, Montpellier, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4353 (2006.01); C07D 471/04 (2006.01); A61P 35/00 (2006.01); C07D 519/00 (2006.01); C07F 9/6561 (2006.01); C07D 491/048 (2006.01); C07D 491/113 (2006.01); C07D 491/107 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/4353 (2013.01); A61P 35/00 (2018.01); C07D 491/048 (2013.01); C07D 491/107 (2013.01); C07D 491/113 (2013.01); C07D 519/00 (2013.01); C07F 9/6561 (2013.01);
Abstract

The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.


Find Patent Forward Citations

Loading…